21 U.S.C. § 2001
Designation of United States Anti-Doping Agency
The term “United States Olympic Committee” means the organization established by the “Ted Stevens Olympic and Amateur Sports Act” (36 U.S.C. 220501 et seq.).
The term “amateur athletic competition” means a contest, game, meet, match, tournament, regatta, or other event in which amateur athletes compete (36 U.S.C. 220501(b)(2)).
The term “amateur athlete” means an athlete who meets the eligibility standards established by the national governing body or paralympic sports organization for the sport in which the athlete competes (36 U.S.C. 22501(b)(1)).1
Any action taken by the United States Anti-Doping Agency to enforce a policy, procedure, or requirement of the United States Anti-Doping Agency against a person with respect to a violation of Federal law, including an investigation, a disciplinary action, a sanction, or any other administrative action, shall be carried out in a manner that provides due process protection to the person.
The Ted Stevens Olympic and Amateur Sports Act, referred to in subsec. (a)(1), is chapter 2205 of Title 36, Patriotic and National Observances, Ceremonies, and Organizations.
2022—Subsec. (b)(1). Pub. L. 117–103, § 303(1)(A), amended par. (1) generally. Prior to amendment, par. (1) read as follows: “serve as the independent anti-doping organization for the amateur athletic competitions recognized by the United States Olympic Committee and be recognized worldwide as the independent national anti-doping organization for the United States;”.
Subsec. (b)(5). Pub. L. 117–103, § 303(1)(B), (C), added par. (5).
Subsec. (c). Pub. L. 117–103, § 303(2), added subsec. (c).
2014—Subsec. (a)(4). Pub. L. 113–280, § 2(1), struck out par. (4). Text read as follows: “The term ‘gene doping’ means the nontherapeutic use of cells, genes, genetic elements, or of the modulation of gene expression, having the capacity to enhance athletic performance.”
Subsec. (b)(1). Pub. L. 113–280, § 2(2)(A), inserted “and be recognized worldwide as the independent national anti-doping organization for the United States” after “Committee”.
Subsec. (b)(2). Pub. L. 113–280, § 2(2)(B), substituted “or prohibited performance-enhancing methods adopted by the Agency” for “, or performance-enhancing genetic modifications accomplished through gene-doping”.
Subsec. (b)(3). Pub. L. 113–280, § 2(2)(C), substituted “or prohibited performance-enhancing methods adopted by the Agency” for “, or performance-enhancing genetic modifications accomplished through gene-doping”.
Subsec. (b)(4). Pub. L. 113–280, § 2(2)(D), substituted “, and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency.” for “and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and”.
Subsec. (b)(5). Pub. L. 113–280, § 2(2)(E), struck out par. (5) which read as follows: “permanently include ‘gene doping’ among any list of prohibited substances adopted by the Agency.”
References to the United States Olympic Committee deemed to refer to the United States Olympic and Paralympic Committee, see section 220502(c) of Title 36, Patriotic and National Observances, Ceremonies, and Organizations.
Pub. L. 117–103, div. Q, title III, § 301,
Pub. L. 113–280, § 1,
Pub. L. 109–469, title X, § 1001,
Pub. L. 117–103, div. Q, title III, § 302,